Filana Therapeutics FLNA
NASDAQ FLNA
$0.65 -0.01 (-1.52%)
At close: Oct 22, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Selling, General & Administrative (2010 - 2026)

Updated

Filana Therapeutics (FLNA) posted Selling, General & Administrative of $6.09 million for Q2 2026, down 84.9% from $40.28 million a year earlier and down 8.1% from the prior quarter.

Analysis

Filana Therapeutics (FLNA) Selling, General & Administrative (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Filana Therapeutics was $30.32 million, down 58.5% year-over-year; for FY2025, it was $68.8 million, down 4.2% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 79.0% (FY2020 to FY2025).
  • In prior years, Filana Therapeutics' Selling, General & Administrative was $71.81 million in FY2024 (+334.3%), $16.53 million in FY2023 (+37.9%), $11.99 million in FY2022 (+48.8%) and $8.06 million in FY2021 (+115.4%).
  • The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q1 2024.
  • On a year-over-year basis, Selling, General & Administrative increased in four of the last eight quarters, with growth averaging 43.9%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 271.2%; the weakest was Q2 2026, with a decline of 84.9%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $6.62 million (Q1 2026), $9.7 million (Q4 2025) and $7.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.29 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.63 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 5.65 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.92 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 3.41 Bn
10 Filana Therapeutics 31.40 Mn -339.44 Mn - 6.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.09 Mn
Mar 31, 2026 6.62 Mn
Dec 31, 2025 9.70 Mn
Sep 30, 2025 7.91 Mn
Jun 30, 2025 40.28 Mn
Mar 31, 2025 10.92 Mn
Dec 31, 2024 8.96 Mn
Sep 30, 2024 12.95 Mn
Jun 30, 2024 46.20 Mn
Mar 31, 2024 3.70 Mn
Dec 31, 2023 4.06 Mn
Sep 30, 2023 4.28 Mn
Jun 30, 2023 3.81 Mn
Mar 31, 2023 4.39 Mn
Dec 31, 2022 3.29 Mn
Sep 30, 2022 2.82 Mn
Jun 30, 2022 2.97 Mn
Mar 31, 2022 2.92 Mn
Dec 31, 2021 4.10 Mn
Sep 30, 2021 1.71 Mn
API Access

Filana Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=FLNA&period=max&api_key=YOUR_API_KEY